Intuitive Surgical (ISRG) Stock: Buy, Sell, or Hold?
ISRG - Intuitive Surgical Inc.
$369.15
8.69 (2.41%)
â˛
5d:
-0.18%
30d:
-8.0%
90d:
-10.6%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Oct 20, 2026
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Sep 4, 2026 at $366.70 · last confirmed Sep 11, 2026
Strength: 7.2/10
Get Alerted When ISRG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: ISRG is fairly priced but lacks strong directional signals. At -9.5% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: ISRG is fairly priced but lacks strong directional signals. At -9.5% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$442.68
Based on 8.0% avg growth
INTRINSIC VALUE TODAY
$274.87
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ISRG is currently trading at $369.15, which is considered slightly low relative to its 30-day fair value range of $363.65 to $390.73. From a valuation perspective, the stock is trading at a discount (Forward PE: 30.6) compared to its historical average (41.3). Remarkably, the market is currently pricing in an annual earnings decline of 9.5% over the next few years. This pessimistic expectation contrasts with the company's recent 26.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ISRG is in a strong downtrend. Immediate support is located at $345.25, while resistance sits at $382.41.
Market Sentiment: ISRG scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $478.01 (+29.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ISRG is in a strong downtrend. Immediate support is located at $345.25, while resistance sits at $382.41.
Market Sentiment: ISRG scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $478.01 (+29.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$363.65 -
$390.73
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
90.5%
Protect Your Profits
Holding ISRG? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (70/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 29.5% below Wall St target ($478.01)
- WARNING: Composite score 53/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$363.65 -
$390.73
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$345.25
Resistance Level
$382.41
Current Trend
Strong Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
30.58
Wall Street Target
$478.01
(+29.5%)
Revenue Growth (YoY)
18.5%
Earnings Growth (YoY)
26.5%
Profit Margin
28.4%
Valuation Discount vs History
-9.5% cheaper
PE vs Historical
30.6 vs 41.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.5%
(market-implied from PE analysis)
1-Year Target
$334.08
(-10%)
2-Year Target
$302.34
(-18%)
3-Year Target
$273.62
(-26%)
3-Yr Target (if PE normalizes)
(PE: 31â41)
$369.55
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 30.6, Growth: 12.0%)
$518.48
(+41%)
Base:
(SPY PE: 20.2, Growth: 12.0%)
$341.99
(-7%)
Bear:
(PE: 17.1, Growth: 12.0%)
$290.69
(-21%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (41x PE), but valuation improves significantly next year (31x PE) as earnings recover.
Trailing PE: 40.50 | Current EPS (TTM): $8.90
Bull Case
$537.82
(+46%)
Analyst growth 35.6%, PE expands to 44.6
Base Case
$488.93
(+32%)
Market implied 35.6%, PE stable at 40.5
Bear Case
$245.11
(-34%)
Severe decline -20.0%, PE contracts to 34.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 30.6 to 41.3
Stabilization Target:
$498.57
(+35.1%)
PE Expansion Potential:
+35.1%
Share & Embed Analysis
Last updated: September 13, 2026 2:31 AM ET
Data refreshes hourly during market hours. Next update: 3:31 AM
Data refreshes hourly during market hours. Next update: 3:31 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ISRG showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
NEUTRAL
Recent Transactions
Ro Khanna
BUY
2026-03-23
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 35 SELL |
|
WST
West Pharmaceutical ServâĻ |
STRONG BUY
13 analysts |
$405 | 63 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$188 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$246 | 41 HOLD |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$82 | 43 HOLD |
Advanced ISRG Option Strategies
Professional options setups generated by AI based on today's ISRG price and gamma walls.
